ArticleBMC endocrine disorders2025
Predictive modeling of graves' orbitopathy activity based on meibomian glands analysis using in vivo confocal microscopy.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThis study aims to identify indicators of disease activity in patients with graves' orbitopathy (GO) by examining the microstructural characteristics of meibomian glands (MGs) and developed a diagnostic model.
methodsWe employed in vivo confocal microscopy (IVCM) to examine MGs in GO patients. Patients classified in the active phase were determined based on the clinical activity score (CAS). The research employed the least absolute shrinkage and selection operator (LASSO) method to select key indicators. Subsequently, a logistic regression model was constructed to predict GO disease activity.
resultsA total of 45 GO patients, corresponding to 90 eyes, were included in this study. A Lasso regression algorithm was utilized to select the predictor variables. Five predictor variables were included in our diagnostic model ultimately. The area under the curve (AUC) for the training set model reached 0.959, and for the validation set was 0.969. The training set and validation set models both demonstrated high accuracy in calibration. Finally, a Nomogram chart was constructed to visualize the diagnostic model.
conclusionWe constructed a diagnostic model based on microstructural indicators of MGs obtained through IVCM and offered a clinical utility for assessing GO disease activity, aiding in the diagnosis and selection of treatment strategies for GO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.